Citius Oncology restructures $14.1M payment obligation to Eisai for LYMPHIR milestone and development costs

CITIUS ONCOLOGY, INC.

Total owed: $5.9M milestone payment plus $8.23M in development and inventory costs.
Payment schedule: $2.535M due July 15, 2025; then four monthly $2.35M payments; final $2.198M due Dec 15, 2025.
Interest at 2% per annum accrues from original due dates until actual payment.
Parties release each other from claims related to past non-payment; License Agreement otherwise unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.